申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0279398A1
公开(公告)日:1988-08-24
Fungal infections of the skin and mucous membranes may be controlled by topical administration of a pharmaceutical composition comprising a N-(3- or 4-alkylphenyl)-4,5-dihydro-2-thiazolamine.
皮肤和粘膜的真菌感染可通过局部使用包含 N-(3-或 4-烷基苯基)-4,5-二氢-2-噻唑胺的药物组合物来控制。